First published 9/30/2026, 9:26:15 AM · Last updated 9/30/2026, 9:26:15 AM

Oral administration of melatonin modulates macrophage polarization via modulating the Vegf signaling pathway and ameliorates Alzheimer’s disease in APP/PS1 mice

A journal article reports that oral melatonin alters macrophage polarization through the VEGF signaling pathway and reduces Alzheimer’s-like disease measures in APP/PS1 mice. The supplied excerpt contains no additional methodological, quantitative, or location details beyond the publication metadata.

Categories: science-and-space, public-health, positive-progress

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

This preclinical result may be relevant to Alzheimer's disease research directions.

Sources

Oral administration of melatonin modulates macrophage polarization via modulating the Vegf signaling pathway and ameliorates Alzheimer’s disease in APP/PS1 mice

Report an issue